Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 10, 2025

Primary Completion Date

December 1, 2027

Study Completion Date

December 1, 2028

Conditions
Medullary Thyroid Carcinoma
Interventions
DIAGNOSTIC_TEST

68Ga-DOTA-CCK-FS PET/CT

For 68Ga-DOTA-CCK-FS, imaging begins 60±5 minutes post-injection to evaluate cholecystokinin receptor (CCK-R) expression, using a time-of-flight PET/CT system with low-dose CT (120 kVp, 30-50 mAs) for attenuation correction followed by whole-body PET acquisition (2-3 min/bed position). Images are reconstructed using OSEM algorithms.

Trial Locations (1)

100730

RECRUITING

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
collaborator

Peking Union Medical College Hospital

OTHER

lead

Luo Yaping

OTHER